Št. zadetkov: 9
Diplomsko delo
Oznake:
razvrščanje;planiranje;APS;proizvodnja;kriteriji;računalništvo;visokošolski strokovni študij;računalništvo in informatika;diplomske naloge;
Proizvodna podjetja danes potrebujejo napredno planiranje in razvrščanje proizvodnje, da lahko ostajajo konkurenčna. Odločitev, kateri program izbrati za ta namen, pa je prepuščena njim samim, saj na trgu ni orodja, ki bi jim pri tem sistematično pomagalo. Zato smo se odločili razviti orodje za izbi ...
Leto:
2014
Vir:
Fakulteta za računalništvo in informatiko (UL FRI)
Diplomsko delo
Oznake:
razvrščanje;planiranje;APS;proizvodnja;kriteriji;
Proizvodna podjetja danes potrebujejo napredno planiranje in razvrščanje proizvodnje, da lahko ostajajo konkurenčna. Odločitev, kateri program izbrati za ta namen, pa je prepuščena njim samim, saj na trgu ni orodja, ki bi jim pri tem sistematično pomagalo. Zato smo se odločili razviti orodje za izbi ...
Leto:
2014
Vir:
Fakulteta za računalništvo in informatiko (UL FRI)
Pregledni znanstveni članek
Oznake:
microsampling;DBS;VAMS;mAbs;TDM;inflammatory diseases;
Monoclonal antibodies (mAbs) have been extensively developed over the past few years, for the treatment of various inflammatory diseases. They are large molecules characterized by complex pharmacokinetic and pharmacodynamic properties. Therapeutic drug monitoring (TDM) is routinely implemented in th ...
Leto:
2021
Vir:
Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake:
možne interakcije med zdravili;abdominalni stent-graft;program medsebojnega delovanja zdravil;simptomi in znaki;dejavniki tveganja;potential drug—drug interactions;schizophrenia;antipsychotics;drug interaction program;symptoms and signs;risk factors;
Background and Objectives: Patients with schizophrenia are often exposed to polypharmacotherapy, which may lead to drug—drug interactions. The aim of the study was to investigate the prevalence of potential drug—drug interactions (pDDIs) in hospitalized patients with schizophrenia spectrum disorders ...
Leto:
2023
Vir:
Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake:
posušena krvna lisa;lamotrigin;lamotrigin glukuronid;terapevtsko spremljanje zdravil;klinična validacija;učinek hematokrita;dried blood spot;lamotrigine;lamotrigine glucuronide;therapeutic drug monitoring;clinical validation;haematocrit effect;
Background: The antiepileptic drug lamotrigine (LTG) shows high pharmacokinetic variability due to genotype influence and concomitant use of glucuronidation inducers and inhibitors, both of which may be frequently taken by elderly patients. Our goal was to develop a reliable quantification method fo ...
Leto:
2024
Vir:
Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake:
small cell lung cancer;platinum-etoposide chemotherapy;etoposide;febrile neutropenia;plasma drug concentration;
Chemotherapy with platinum agent and etoposide for small-cell lung cancer (SCLC) is supposed to be associated with intermediate risk (10-20%) of febrileneutropenia. Primary prophylaxis with granulocyte colonystimulating factors (G-CSFs) is not routinely recommended by the treatment guidelines. Howev ...
Leto:
2015
Vir:
Digitalni repozitorij raziskovalnih organizacij Slovenije
Izvirni znanstveni članek
Oznake:
pharmacy education;Slovenian curriculum;pharmacy profession;
This article presents the results of mapping the Slovenian pharmacy curriculum to evaluate the adequacy of the recently developed and validated European Pharmacy Competences Framework (EPCF). The mapping was carried out and evaluated progressively by seven members of the teaching staff at the Univer ...
Leto:
2017
Vir:
Fakulteta za farmacijo (UL FFA)
Doktorska disertacija
Oznake:
veterinarstvo;športni konji;vadba;lipidna peroksidacija;kri;kemična analiza;prehrana;antioksidanti;koencim Q10;
Farmakokinetika koencima Q10 pri športnih konjih kasačih in njegov pomen pri preprečevanju oksidativnega stresa pri vadbi
Leto:
2012
Vir:
Veterinarska fakulteta (UL VF)
Jurij Zdovc,
Jurij Hanžel,
Tina Kurent,
Nejc Sever,
Matic Koželj,
Nataša Smrekar,
Gregor Novak,
Borut Štabuc,
Tomaž Vovk,
Barbara Ostanek,
David Drobne,
Iztok Grabnar
Izvirni znanstveni članek
Oznake:
vnetje črevesja;terapevtsko spremljanje zdravil;fekalni kalprotektin;ustekinumab;inflammatory bowel disease;fecal calprotectin;pharmacokinetics-pharmacodynamics;therapeutic drug monitoring;
Ustekinumab is a monoclonal antibody used in Crohn's disease (CD). Dose optimization in case of non-response and the role of pharmacokinetic-pharmacodynamic (PK-PD) monitoring remain unresolved dilemmas in clinical practice. We aimed to develop a population PK-PD model for ustekinumab in CD and simu ...
Leto:
2021
Vir:
Fakulteta za farmacijo (UL FFA)